Grip strength as a biomarker: what the prospective data shows

Grip strength (measured with a hand-held dynamometer) keeps appearing in prospective cohort studies as one of the strongest single-measurement predictors of long-term outcomes. It's free, takes 30 seconds, and the relationship survives extensive adjustment for confounders.

The headline finding#

The PURE study (Leong et al. 2015, Lancet) followed 139,691 adults across 17 countries for a median of four years. After adjustment for age, sex, education, smoking, alcohol, physical activity, BMI, and other factors:

• Each 5 kg lower grip strength was associated with 16% higher all-cause mortality.
• The relationship held for cardiovascular mortality, non-cardiovascular mortality, MI, and stroke.
• The predictive value was actually stronger than systolic blood pressure for mortality.

Multiple subsequent cohort studies (Health ABC, UK Biobank, Hong Kong cohorts) have replicated the direction and rough magnitude.

Why it might be predictive#

A few overlapping mechanisms are plausible:

• It's a proxy for total muscle quality and quantity. Sarcopenia is a strong risk factor for ageing-related decline.
• It's a proxy for overall vitality. People who can grip strongly are typically those who move more, eat better, and have fewer comorbidities.
• It reflects neuromuscular integrity. Maximal voluntary contraction requires central drive and intact motor unit function.

The correlation is probably part proxy, part mechanism. The clinical use case is that it's a cheap, non-invasive way to spot patients who might benefit from a closer look.

What's actually low#

There's no single universal threshold; norms are age- and sex-stratified. The cut-offs used in clinical sarcopenia screening (EWGSOP2):

• <27 kg for men
• <16 kg for women

are conservative; below these, sarcopenia screening is warranted. Healthy young adults are typically 40–60+ kg (men) and 25–40+ kg (women); these decline with age.

How to measure#

A Jamar or Camry hand dynamometer is the standard. Three trials per hand, take the best. The right hand and left hand should be within roughly 10% of each other in right-handed people; large asymmetries are themselves a flag for further investigation.

Cheap consumer dynamometers (~£30) give reasonable reads for tracking trends; they may not match clinical Jamar values exactly.

How to train it#

Grip strength responds to training. Most resistance work improves it indirectly. Specific grip work:

• Farmer's carries (walking with heavy weights in hands)
• Dead hangs (hanging from a bar for time)
• Heavy rowing and deadlifting (training holds at top of pull)
• Dedicated grip work (plate pinches, gripper devices)

Two or three short sessions a week added to a normal resistance training routine can move the number measurably over 8–12 weeks.

What the biomarker doesn't mean#

A low grip strength does not cause early mortality. The relationship is associative. Working on grip strength alone, without addressing the underlying reasons it might be low (low muscle mass, poor nutrition, sedentary behaviour, comorbidities), is unlikely to move long-term outcomes.

The useful framing: grip strength is the canary, not the mine. If it's low for your age and sex, it's a reasonable cue to look at general resistance training, protein intake, and overall activity level. If it's robust, it's evidence the broader picture is reasonably intact.

Where to test#

Some NHS frailty assessment pathways measure grip strength in older patients. Most private health checks now include it. At home, a £30 dynamometer is sufficient to track trends, which is the more useful read than chasing an absolute number against population norms.